Precision BioSciences

precisionbiosciences.com

Precision Biosciences, Inc. (NASDAQ: DTIL) is a pre-clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile Arcus genome editing platform. Arcus uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision Biosciences is based in Durham, North Carolina. For more information about Precision Biosciences, please visit www.precisionbiosciences.com.